Skip to main navigation

Main Nav

About Us
Scientific Platform
Our Pipeline
Career Opportunities
Investors & Media

Press Releases

IR Nav

Overview
Press Releases
Events
Presentations
Annual Reports
Corporate Governance
SEC Filings
Stock Information
Analyst Coverage
FAQs
Email Alerts
Investor Contact

Shareholder Tools

Press Releases

Year

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 13, 2023

Gritstone bio to Participate in Upcoming Investor Conferences

September 5, 2023

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 16, 2023

Gritstone bio and Genevant Sciences Announce Option and License Agreement

August 15, 2023

Gritstone bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updates

August 9, 2023

Gritstone bio Partners with Friends of Cancer Research (Friends) on the ctDNA to Monitor Treatment Response (ctMoniTR) Project

August 7, 2023

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 17, 2023

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 13, 2023

Gritstone bio Announces Publication of Interim Results from Phase 1 Study of Self-amplifying mRNA (samRNA) Vaccine Against COVID-19 in Nature Communications

June 8, 2023

Gritstone bio to Participate in Upcoming Investor Conferences

June 1, 2023

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

© 2024 Gritstone Bio |

Footer Links

Privacy Policy
Terms of Use
Cookie Policy
Contact

socials

Top